State Sen. Jason Prokop introduced the measure, which would require insurance companies to cover certain Food and Drug ...

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting ...

Public drug plans should not cover lecanemab, a drug to slow early-stage Alzheimer's disease, Canada's Drug Agency says in its draft recommendation.

A new blood test could predict when Alzheimer’s will strike — years before symptoms begin. Scientists at Washington University School of Medicine in St. Louis have created a way to estimate when a ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...